MedPath

Northwestern University Human Resources

Northwestern University Human Resources logo
🇺🇸United States
Ownership
Private
Established
1851-01-28
Employees
5K
Market Cap
-
Website
https://www.venturecat.northwestern.edu

The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination

Not Applicable
Completed
Conditions
Influenza Vaccination
Interventions
Behavioral: Fact and Myth Educational Message
Behavioral: Fact, Myth, Why Educational Message
Behavioral: Fact Only Education Message
Behavioral: Control Educational Message
First Posted Date
2009-11-09
Last Posted Date
2023-10-30
Lead Sponsor
Northwestern University
Target Recruit Count
125
Registration Number
NCT01009645
Locations
🇺🇸

Northwestern Medical Faculty Foundation General Internal Medicine and Geriatric Clinics, Chicago, Illinois, United States

Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome

Phase 1
Terminated
Conditions
Myelodysplastic Syndromes
Interventions
First Posted Date
2009-11-06
Last Posted Date
2013-11-08
Lead Sponsor
Northwestern University
Target Recruit Count
1
Registration Number
NCT01009502
Locations
🇺🇸

Jesse Brown VHA Medical Center, Chicago, Illinois, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

Erlotinib for Treatment of Psoriasis

Phase 2
Withdrawn
Conditions
Psoriasis
Interventions
Other: placebo tablet
First Posted Date
2009-11-01
Last Posted Date
2014-11-10
Lead Sponsor
Northwestern University
Registration Number
NCT01006096
Locations
🇺🇸

Northwestern University Feinberg School of Medicine Department of Dermatology, Chicago, Illinois, United States

Clearance of Nasal Staphylococcus Aureus With Triple Antibiotic Ointment

Not Applicable
Completed
Conditions
Nasal Carriers of Staphylococcus Aureus
First Posted Date
2009-10-19
Last Posted Date
2015-01-05
Lead Sponsor
Northwestern University
Target Recruit Count
216
Registration Number
NCT00997139
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

Phase 2
Completed
Conditions
HIV-1 Infection
HIV Infections
Interventions
First Posted Date
2009-10-12
Last Posted Date
2014-09-05
Lead Sponsor
Northwestern University
Target Recruit Count
25
Registration Number
NCT00993148
Locations
🇺🇸

University of Miami, Miami, Florida, United States

🇺🇸

Quest Clinical Research, San Francisco, California, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

and more 2 locations

Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia

Early Phase 1
Completed
Conditions
Brain Neoplasms
Intracranial Aneurysm
Interventions
First Posted Date
2009-10-09
Last Posted Date
2019-12-13
Lead Sponsor
Northwestern University
Target Recruit Count
120
Registration Number
NCT00993057
Locations
🇺🇸

Dhanesh Gupta, Chicago, Illinois, United States

Pilot Study of Stellate Ganglion Injection to Provide Relief From Hot Flushes

Not Applicable
Completed
Conditions
Menopause
Hot Flashes
Interventions
Procedure: Sympathetic nerve block with 1% lidocaine 1-2 ml
Procedure: Superficial subcutaneous injection
First Posted Date
2009-10-09
Last Posted Date
2019-05-10
Lead Sponsor
Northwestern University
Target Recruit Count
40
Registration Number
NCT00992914
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide

Phase 2
Completed
Conditions
Brain and Central Nervous System Tumors
Interventions
First Posted Date
2009-10-07
Last Posted Date
2014-01-13
Lead Sponsor
Northwestern University
Target Recruit Count
10
Registration Number
NCT00990652
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia

Phase 1
Terminated
Conditions
Acute Promyelocytic Leukemia
Interventions
First Posted Date
2009-09-28
Last Posted Date
2013-10-30
Lead Sponsor
Northwestern University
Target Recruit Count
4
Registration Number
NCT00985530
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer

Phase 1
Completed
Conditions
Metastatic Breast Cancer
Interventions
Drug: Cyclosporins
First Posted Date
2009-09-24
Last Posted Date
2013-09-16
Lead Sponsor
Northwestern University
Target Recruit Count
14
Registration Number
NCT00983424
Locations
🇺🇸

Northwestern University, Northwestern Medical Faculty Foundation, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath